Sofosbuvir/simeprevir versus sofosbuvir/ribavirin regimen in Egyptian patients with hepatitis C virus
Conclusion
A 12-week course of sofosbuvir/simeprevir showed a higher response rate than 24 weeks of sofosbuvir/ribavirin among patients with HCV-related Child A cirrhosis.
Source: Egyptian Liver Journal - Category: Gastroenterology Tags: Original articles Source Type: research
More News: Children | Cirrhosis | Egypt Health | Hepatitis | Hepatitis C | Liver | Smokers | Study | Urology & Nephrology | Virology